Cargando…
Trisomy 21 as a Risk Factor for Severe Illness in COVID-19: Report of two Cases
COVID-19 leads to mild symptoms within the majority of infected patients, but can cause severe multiple organ failure and death. There is only limited information regarding the consequences of this new emerging infection with congenital disorders. According to the previous studies, many people with...
Autores principales: | Babamahmoodi, Abdolreza, Moniri, Afshin, Sadr, Makan, Poorhosseini, Seyed Mohammad, Rezaei, Mitra, Marjani, Majid, Velayati, Ali Akbar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Research Institute of Tuberculosis and Lung Disease
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8088146/ https://www.ncbi.nlm.nih.gov/pubmed/33959180 |
Ejemplares similares
-
Evaluation of Silymarin for management of anti-tuberculosis drug induced liver injury: a randomized clinical trial
por: Marjani, Majid, et al.
Publicado: (2019) -
NRITLD Protocol for the Management of Outpatient Cases of COVID-19
por: Rezaei, Mitra, et al.
Publicado: (2021) -
Bruton's Tyrosine Kinase: A Promising Target for the Treatment of COVID-19
por: Rezaei, Mitra, et al.
Publicado: (2020) -
The Possible Role of Bruton Tyrosine Kinase Inhibitors in the Treatment of COVID-19: A Review
por: Rezaei, Mitra, et al.
Publicado: (2021) -
Etiology of Respiratory Complications among Iranian HIV Infected Patients
por: Marjani, Majid, et al.
Publicado: (2019)